Methylated Gene Primer Panel for Accurate Colorectal Cancer Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for diagnosing colorectal cancer lack sensitivity and specificity in detecting methylation of colorectal cancer marker genes, limiting their effectiveness in early detection and diagnosis.

Innovation Solution

Utilizing primers that specifically amplify multiple methylated colorectal cancer marker genes, such as SDC2 and ADHFE1, in combination with reagents that modify methylated and non-methylated DNA, followed by PCR and probe hybridization to enhance detection accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If existing detection methods are used for colorectal cancer diagnosis, then the detection process is simple, but the sensitivity and specificity are insufficient

Engineering Contradiction:
Improvedetection accuracyVSAvoiddetection process complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The detection process is segmented into distinct functional steps: DNA extraction, methylation-specific PCR amplification using primers designed to target methylated CpG islands, and detection of amplified products. This segmentation allows each step to be optimized independently, improving overall detection accuracy while maintaining procedural clarity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method changes key parameters including using methylation-specific primers with specific sequences that bind only to methylated DNA regions, adjusting PCR conditions to favor amplification of methylated templates, and detecting methylation status rather than gene expression. These parameter changes enable high sensitivity and specificity detection.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If multiple methylated marker genes are detected simultaneously, then the sensitivity and specificity improve, but the detection complexity increases

Engineering Contradiction:
Improvediagnosis reliabilityVSAvoiddetection system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Multiple methylation detection assays for different marker genes (such as SDC2, ADHFE1, and other colorectal cancer-associated genes) are merged into a single integrated detection system. The method combines multiple primer sets targeting different CpG islands in one workflow, allowing simultaneous detection of multiple markers without requiring separate detection systems for each gene, thus improving reliability while controlling complexity.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Improves the sensitivity and specificity of colorectal cancer diagnosis by detecting methylation patterns in samples like stool, blood, or plasma, enabling early and accurate detection of the disease.

Implementation Method 1

treating a sample with at least one reagent differently modifying methylated SDC2 (syndecan 2) and ADHFE1 (alcohol dehydrogenase iron-containing 1) genes and non-methylated SDC2 and ADHFE1 genes

Methodology Applied
Scientific EffectBisulfite modification:

Implementation Method 2

performing treatment with primers specifically amplifying the methylated SDC2 and ADHFE1 genes

Methodology Applied
Scientific EffectPCR amplification:

Implementation Method 3

followed by PCR and probe hybridization to enhance detection accuracy

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS12577623B2Method for detecting colorectal cancer
Publication Date: 2026.03.17 GENOMICTREE
  • US12577623B2 patent drawing
  • US12577623B2 patent drawing
  • US12577623B2 patent drawing

AI summary

The present invention relates to a method for providing information for colorectal cancer diagnosis, a composition for diagnosing colorectal cancer, and a kit comprising same, and, more particularly, to: a method for providing information for colorectal cancer diagnosis by using a primer for specifically amplifying plural methylated colorectal cancer marker genes; a composition for diagnosing colorectal cancer; and a kit comprising same.